$CRSP was mentioned 13 times over a 12-month period from October 22, 2025 to July 17, 2026 by six distinct FinTwit voices, with @adamfeuerstein leading discussion activity at 5 mentions. The long research category dominated discourse around the stock. Most recent mentions occurred in early-to-mid July 2026, with @ftr_investors noting $CRSP trading 38% below its 52-week high as part of a broader next-generation stocks analysis, while @adamfeuerstein discussed competitive dynamics in the gene therapy space including commentary on sickle cell treatments and rival approaches from other companies.